DUNHAM TRUST Co’s Calidi Biotherapeutics CLDI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.4K Hold
3,180
– – ﹤0.01% 273
2026
Q2
$8.65K Buy
+3,180
New +$10.3K ﹤0.01% 223
2025
Q4
$59.5K Buy
+3,180
New +$74.8K 0.04% 128

Other funds holding CLDI

DUNHAM TRUST Co's CLDI Position: Q3 2026 in Review

DUNHAM TRUST Co held its Calidi Biotherapeutics (CLDI) position steady in Q3 2026 at 3,180 shares worth $3.4K. The position accounts for ﹤0.01% of the portfolio, ranked #273.

DUNHAM TRUST Co first reported a position in CLDI in Q4 2025 and has held it in 3 quarters since. The position peaked at $59.5K in Q4 2025. 20 funds tracked by Wall St. Rank hold CLDI as of Q3 2026.

  • DUNHAM TRUST Co held 3,180 shares of Calidi Biotherapeutics worth $3.4K as of Q3 2026.
  • DUNHAM TRUST Co left its Calidi Biotherapeutics share count unchanged in Q3 2026.
  • Calidi Biotherapeutics made up ﹤0.01% of DUNHAM TRUST Co's portfolio in Q3 2026, its #273 holding.
  • DUNHAM TRUST Co first reported a position in Calidi Biotherapeutics in Q4 2025 and has held it in 3 quarters since.
  • DUNHAM TRUST Co's Calidi Biotherapeutics position peaked at $59.5K in Q4 2025.
  • 20 funds tracked by Wall St. Rank held Calidi Biotherapeutics as of Q3 2026.

Based on DUNHAM TRUST Co's 13F filing for Q3 2026, filed 16 Nov 2026.